Clinical Trials for Simbec-Orion Group

Explore 5 clinical trials worldwide

Showing 1-5 of 5 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruitingSponsor: Simbec-Orion Group

Clinical Trials (5)

NCT07148128
Phase 1/2a Study to Assess the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of WEF-001 as Monotherapy in Advanced KRAS-Mutant Solid Tumours.
PHASE1/PHASE2Recruiting
110 participants
Started: Jul 28, 2025 · Completed: Jan 31, 2028
5 conditions2 sponsors3 locations
NCT06280157
A Follow up Study of Group B Streptococcus (GBS)-NN/NN2 Vaccine in Healthy Volunteers
N/AEnrolling by invitation
55 participants
Started: Jan 18, 2024 · Completed: Jan 31, 2028
1 condition2 sponsors1 location
NCT05570058
Assess the Safety, Pharmacokinetics, Pharmacodynamics and Clinical Activity of RXC007 in Idiopathic Pulmonary Fibrosis
PHASE2Active, not recruiting
48 participants
Started: Sep 8, 2022 · Completed: Jan 9, 2025
2 conditions2 sponsors31 locations
NCT05486182
Impact of 18F-FES PET on the Therapeutic Treatment of Patients With Metastatic Breast Cancer
PHASE4Active, not recruiting
153 participants
Started: Feb 8, 2022 · Completed: Jan 31, 2026
1 condition3 sponsors11 locations
NCT04832607
Multivirus-specific T-cell Transfer Post SCT vs AdV, CMV and EBV Infections
PHASE3Recruiting
149 participants
Started: Aug 27, 2019 · Completed: Sep 30, 2028
4 conditions10 sponsors33 locations